Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Antioxid Redox Signal ; 7(7-8): 863-9, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-15998241

RESUMEN

Tyrosine hydroxylase (TH) is the initial and rate-limiting enzyme in the biosynthesis of the neurotransmitter dopamine. Peroxynitrite (ONOO-) and nitrogen dioxide (NO2) inhibit TH catalytic function and cause nitration of protein tyrosine residues. Exposure of TH to either ONOO- or NO2 in the presence of cysteine (or glutathione) prevents tyrosine nitration and results in S-thiolation instead. TH catalytic activity is suppressed by S-thiolation. Dithiothreitol prevents and reverses the modification of TH by S-thiolation, and returns enzyme activity to control levels. S-Nitrosothiols, which are known to S-thiolate proteins, can be formed in the reaction of cysteine or glutathione with reactive nitrogen species. Therefore, S-nitrosoglutathione (GSNO) was tested for its ability to modify TH. Fresh solutions of GSNO did not modify TH, whereas decomposed GSNO resulted in extensive S-thiolation of the protein. Dimedone, a sulfenic acid trap, prevents S-thiolation of TH when included with GSNO during its decomposition. Taken together, these results show that TH is S-thiolated by ONOO- or NO2 in the presence of cysteine. S-Thiolation occurs at the expense of tyrosine nitration. Glutathione disulfide S-oxide, which forms spontaneously in the decomposition of GSNO and which is found in tissue undergoing oxidative stress, may be the species that S-thiolates TH.


Asunto(s)
Cisteína/farmacología , Especies de Nitrógeno Reactivo/metabolismo , S-Nitrosoglutatión/farmacología , Compuestos de Sulfhidrilo/metabolismo , Tirosina 3-Monooxigenasa/metabolismo , Biotinilación , Cisteína/química , Diaminas/farmacología , Nitratos/metabolismo , Óxido Nítrico/farmacología , Estrés Oxidativo/efectos de los fármacos
2.
Biochimie ; 91(5): 577-85, 2009 May.
Artículo en Inglés | MEDLINE | ID: mdl-19278624

RESUMEN

Reactive oxygen species such as hydrogen peroxide (H(2)O(2)) are involved in many cellular processes that positively and negatively regulate cell fate. H(2)O(2), acting as an intracellular messenger, activates phosphatidylinositol-3 kinase (PI3K) and its downstream target Akt, and promotes cell survival. The aim of the current study was to understand the mechanism by which PI3K/Akt signaling promotes survival in SH-SY5Y neuroblastoma cells. We demonstrate that PI3K/Akt mediates phosphorylation of the pro-apoptotic Bcl-2 family member Bax. This phosphorylation suppresses apoptosis and promotes cell survival. Increased survival in the presence of H(2)O(2) was blocked by LY294002, an inhibitor of PI3K activation. LY294002 prevented Bax phosphorylation and resulted in Bax translocation to the mitochondria, cytochrome c release, caspase-3 activation, and cell death. Collectively, these findings reveal a mechanism by which H(2)O(2)-induced activation of PI3K/Akt influences post-translational modification of Bax and inactivates a key component of the cell death machinery.


Asunto(s)
Peróxido de Hidrógeno/farmacología , Fosforilación/efectos de los fármacos , Proteínas Proto-Oncogénicas c-akt/metabolismo , Proteína X Asociada a bcl-2/metabolismo , Western Blotting , Muerte Celular/efectos de los fármacos , Línea Celular Tumoral , Cromonas/farmacología , Citometría de Flujo , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Humanos , Inmunohistoquímica , Inmunoprecipitación , Mitocondrias/metabolismo , Morfolinas/farmacología , Inhibidores de las Quinasa Fosfoinosítidos-3 , Transducción de Señal/efectos de los fármacos , Transducción de Señal/fisiología
3.
Rev Endocr Metab Disord ; 9(4): 301-14, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-18709457

RESUMEN

Diabetic neuropathy is the most common complication of diabetes, affecting 50% of diabetic patients. Currently, the only treatment for diabetic neuropathy is glucose control and careful foot care. In this review, we discuss the idea that excess glucose overloads the electron transport chain, leading to the production of superoxides and subsequent mitochondrial and cytosolic oxidative stress. Defects in metabolic and vascular pathways intersect with oxidative stress to produce the onset and progression of nerve injury present in diabetic neuropathy. These pathways include the production of advanced glycation end products, alterations in the sorbitol, hexosamine and protein kinase C pathways and activation of poly-ADP ribose polymerase. New bioinformatics approaches can augment current research and lead to new discoveries to understand the pathogenesis of diabetic neuropathy and to identify more effective molecular therapeutic targets.


Asunto(s)
Neuropatías Diabéticas/etiología , Estrés Oxidativo/fisiología , Animales , Glucosa , Productos Finales de Glicación Avanzada/metabolismo , Hexosaminas/metabolismo , Humanos , Inflamación/fisiopatología , Redes y Vías Metabólicas , Membranas Mitocondriales/metabolismo , Modelos Animales , Fosforilación Oxidativa , Poli(ADP-Ribosa) Polimerasas/metabolismo , Proteína Quinasa C/metabolismo , Especies de Nitrógeno Reactivo/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Alcoholes del Azúcar/metabolismo
4.
Curr Drug Targets ; 9(1): 94-100, 2008 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-18220717

RESUMEN

While increasing antioxidant potential is an attractive treatment strategy for diabetic neuropathy, many years of trials using high-dose oral antioxidants have not produced therapeutic results. An increasing understanding of the innate antioxidant response and the pharmacological agents that can regulate this mechanism may open new avenue for drug development. This review describes the current state of antioxidant trials and the potential for targeting the antioxidant response. In combination with antihyperglycemic agents, agents that regulate the antioxidant response may afford superior protection against cellular oxidative injury in diabetes.


Asunto(s)
Antioxidantes/farmacología , Neuropatías Diabéticas/tratamiento farmacológico , Estrés Oxidativo/efectos de los fármacos , Animales , Antioxidantes/metabolismo , Ensayos Clínicos como Asunto , Diabetes Mellitus/fisiopatología , Neuropatías Diabéticas/fisiopatología , Sistemas de Liberación de Medicamentos , Quimioterapia Combinada , Humanos , Hipoglucemiantes/farmacología , Hipoglucemiantes/uso terapéutico
5.
J Neurochem ; 89(3): 529-36, 2004 May.
Artículo en Inglés | MEDLINE | ID: mdl-15086510

RESUMEN

This review examines the involvement of nitrotyrosine as a marker for peroxynitrite-mediated damage in the dopamine neuronal system. We propose that the dopamine neuronal phenotype can influence the cytotoxic signature of peroxynitrite. Dopamine and tetrahydrobiopterin are concentrated in dopamine neurons, and both are essential for their proper neurochemical function. It is not well appreciated that dopamine and tetrahydrobiopterin are also powerful blockers of peroxynitrite-induced tyrosine nitration. What is more, the reaction of peroxynitrite with either dopamine or tetrahydrobiopterin forms chemical species (i.e. o-quinones and pterin radicals, respectively) whose cytotoxic effects may be manifested far earlier than nitrotyrosine formation in the course of dopamine neuronal damage. A better understanding of how the dopamine neuronal phenotype modulates the effects of reactive nitrogen species could reveal early steps in drug- and disease-induced damage to the dopamine neuron and form the basis for rational, protective therapies.


Asunto(s)
Biopterinas/análogos & derivados , Dopamina/metabolismo , Neuronas/metabolismo , Ácido Peroxinitroso/metabolismo , Tirosina/análogos & derivados , Tirosina/metabolismo , Animales , Biomarcadores , Biopterinas/metabolismo , Humanos , Neuronas/efectos de los fármacos , Ácido Peroxinitroso/toxicidad , Quinonas/metabolismo
6.
J Biol Chem ; 277(16): 14336-42, 2002 Apr 19.
Artículo en Inglés | MEDLINE | ID: mdl-11834745

RESUMEN

Tyrosine hydroxylase (TH), the initial and rate-limiting enzyme in the biosynthesis of the neurotransmitter dopamine, is inactivated by peroxynitrite. The sites of peroxynitrite-induced tyrosine nitration in TH have been identified by matrix-assisted laser desorption time-of-flight mass spectrometry and tyrosine-scanning mutagenesis. V8 proteolytic fragments of nitrated TH were analyzed by matrix-assisted laser desorption time-of-flight mass spectrometry. A peptide of 3135.4 daltons, corresponding to residues V410-E436 of TH, showed peroxynitrite-induced mass shifts of +45, +90, and +135 daltons, reflecting nitration of one, two, or three tyrosines, respectively. These modifications were not evident in untreated TH. The tyrosine residues (positions 423, 428, and 432) within this peptide were mutated to phenylalanine to confirm the site(s) of nitration and assess the effects of mutation on TH activity. Single mutants expressed wild-type levels of TH catalytic activity and were inactivated by peroxynitrite while showing reduced (30-60%) levels of nitration. The double mutants Y423F,Y428F, Y423F,Y432F, and Y428F,Y432F showed trace amounts of tyrosine nitration (7-30% of control) after exposure to peroxynitrite, and the triple mutant Y423F,Y428F,Y432F was not a substrate for nitration, yet peroxynitrite significantly reduced the activity of each. When all tyrosine mutants were probed with PEO-maleimide activated biotin, a thiol-reactive reagent that specifically labels reduced cysteine residues in proteins, it was evident that peroxynitrite resulted in cysteine oxidation. These studies identify residues Tyr(423), Tyr(428), and Tyr(432) as the sites of peroxynitrite-induced nitration in TH. No single tyrosine residue appears to be critical for TH catalytic function, and tyrosine nitration is neither necessary nor sufficient for peroxynitrite-induced inactivation. The loss of TH catalytic activity caused by peroxynitrite is associated instead with oxidation of cysteine residues.


Asunto(s)
Nitrógeno/metabolismo , Ácido Peroxinitroso/farmacología , Tirosina 3-Monooxigenasa/metabolismo , Tirosina/metabolismo , Catálisis , Dopamina/biosíntesis , Electroforesis en Gel de Poliacrilamida , Humanos , Mutagénesis Sitio-Dirigida , Mutación , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , Tirosina/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA